IQ News
Archived Headlines
- Game on: China's HUYA sets terms for $165 million US IPO 05/01/18
- Three companies scheduled to enter the Renaissance IPO ETF (NYSE: IPO) 04/09/18
- US IPO Weekly Recap: 8-IPO week caps record 1Q with a flurry of Chinese deals 03/29/18
- iQIYI prices IPO at $18, within the range 03/29/18
- US IPO Week Ahead: Largest Chinese deal since Alibaba leads 8-IPO week 03/23/18
See more
US IPO Weekly Recap: Keros Therapeutics rises 35% as biotechs beat the IPO shutdown
Another biotech IPO has beaten the market blues. Keros Therapeutics (KROS) finished the week up 35%, affirming that the biotech industry won’t be deterred by current market volatility. Oncology biotech Keros Therapeutics priced its...read more
Renaissance Capital's Updated 2018 US IPO Annual Review
Renaissance Capital has updated the 2018 US IPO Annual Review with returns through December 31. Download a free Preview of the report, and sign up for IPO market updates delivered to your...read more
Mao is Laughing: Capitalists Pour Money into Chinese Companies
Over the past week, two private Chinese technology unicorns, Xiaohongshu (“Little Red Book”) and Sensetime, announced that they had raised nearly $1 billion, adding to the ranks of large Chinese enterprises thinking about going public. Another...read more
US IPO Week Ahead: 2 IPOs in the first week of June; more launches expected
It's a slow start to the typically-active month of June, but that should change soon. Two companies are targeting a combined $158 million in the week ahead. Deals include Taiwan-based live streaming company M17 Entertainment and gene therapy biotech MeiraGTx. ...read more